Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Financial Institutions (FIISP) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Financial Institutions (FIISP) over the last 16 years, with Q3 2025 value amounting to $185.9 million.

  • Financial Institutions' Cash & Equivalents fell 7912.94% to $185.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $185.9 million, marking a year-over-year decrease of 7912.94%. This contributed to the annual value of $87.3 million for FY2024, which is 2983.0% down from last year.
  • Latest data reveals that Financial Institutions reported Cash & Equivalents of $185.9 million as of Q3 2025, which was down 7912.94% from $93.0 million recorded in Q2 2025.
  • In the past 5 years, Financial Institutions' Cash & Equivalents ranged from a high of $1.2 billion in Q4 2021 and a low of $21.0 million during Q1 2022
  • Its 5-year average for Cash & Equivalents is $686.7 million, with a median of $890.9 million in 2024.
  • As far as peak fluctuations go, Financial Institutions' Cash & Equivalents crashed by 9721.81% in 2022, and later skyrocketed by 442881.76% in 2023.
  • Financial Institutions' Cash & Equivalents (Quarter) stood at $1.2 billion in 2021, then decreased by 18.56% to $961.1 million in 2022, then crashed by 87.05% to $124.4 million in 2023, then dropped by 29.83% to $87.3 million in 2024, then skyrocketed by 112.94% to $185.9 million in 2025.
  • Its last three reported values are $185.9 million in Q3 2025, $93.0 million for Q2 2025, and $167.4 million during Q1 2025.